<DOC>
	<DOCNO>NCT00069706</DOCNO>
	<brief_summary>The purpose study determine safety IOP-lowering ability glaucoma therapy patient open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Phase II Safety Efficacy Study Evaluate Glaucoma Therapy Open-angle Glaucoma Ocular Hypertension Patients</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>18 year old . Diagnosis openangle glaucoma ocular hypertension . LogMAR visual acuity bad 0.6 . Other protocoldefined inclusion criterion may apply . Clinically relevant ophthalmic systemic condition . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>open-angle</keyword>
	<keyword>glaucoma</keyword>
	<keyword>ocular</keyword>
	<keyword>hypertension</keyword>
	<keyword>POAG</keyword>
</DOC>